ARCH VENTURE MANAGEMENT, LLC Holdings

ARCH VENTURE MANAGEMENT, LLC is an investment fund managing more than 771.38M US dollars. The largest holdings include Karuna Therapeutics, EQRx and Denali Therapeutics. In Q3 2022 the fund bought assets of total value of 3.97M US dollars and sold assets of total value of 82.2M US dollars.

ARCH VENTURE MANAGEMENT, LLC portfolio value:

$771.38M
portfolio value

ARCH VENTURE MANAGEMENT, LLC quarter portfolio value change:

+45.11%
quarter

ARCH VENTURE MANAGEMENT, LLC 1 year portfolio value change:

+714.36%
1 year

ARCH VENTURE MANAGEMENT, LLC portfolio changes

Portfolio changes (number of shares)
Period Buy Sel
Q3 2019 40015000 21587000
Q4 2019 17438000 36405000
Q4 2021 941869000 11499000
Q3 2022 3970000 82204000

ARCH VENTURE MANAGEMENT, LLC 13F holdings

Stock
KRTX
Biotechnology
Karuna Therapeutics, Inc.
Portfolio share: 38.28%
Portfolio value: 295.30M
Avg. open price: N/A
Current price: $226.95
P/L: N/A
Sold -54.93% shares
Q3 2022
EQRX
Biotechnology
EQRx, Inc.
Portfolio share: 23.32%
Portfolio value: 179.86M
Avg. open price: N/A
Current price: $3.46
P/L: N/A
N/A
Q4 2021
DNLI
Biotechnology
Denali Therapeutics Inc.
Portfolio share: 14.60%
Portfolio value: 112.59M
Avg. open price: N/A
Current price: $30.94
P/L: N/A
Sold -29.02% shares
Q3 2022
ERAS
Biotechnology
Erasca, Inc.
Portfolio share: 11.18%
Portfolio value: 86.23M
Avg. open price: N/A
Current price: $7.28
P/L: N/A
N/A
Q4 2021
VERV
Biotechnology
Verve Therapeutics, Inc.
Portfolio share: 8.95%
Portfolio value: 69.00M
Avg. open price: N/A
Current price: $21.42
P/L: N/A
Sold -19.93% shares
Q3 2022
REVH
Shell Companies
Revolution Healthcare Acquisition Corp.
Portfolio share: 1.73%
Portfolio value: 13.34M
Avg. open price: N/A
Current price: $10.05
P/L: N/A
N/A
Q2 2022
OMIC
Medical Instruments & Supplies
Singular Genomics Systems, Inc.
Portfolio share: 1.23%
Portfolio value: 9.49M
Avg. open price: N/A
Current price: $1.92
P/L: N/A
N/A
Q4 2021
UBX
Biotechnology
Unity Biotechnology, Inc.
Portfolio share: 0.51%
Portfolio value: 3.97M
Avg. open price: N/A
Current price: $2.93
P/L: N/A
N/A
Q3 2022
MTCR
Biotechnology
Metacrine, Inc.
Portfolio share: 0.18%
Portfolio value: 1.42M
Avg. open price: N/A
Current price: $0.41
P/L: N/A
N/A
RUBY
Biotechnology
Rubius Therapeutics, Inc.
Portfolio share: 0.02%
Portfolio value: 152K
Avg. open price: N/A
Current price: $0.19
P/L: N/A
Sold -86.64% shares
Q4 2021
ZY
Specialty Chemicals
Zymergen Inc.
Portfolio share: 0.00%
Portfolio value: 0
Avg. open price: N/A
Current price: $2.43
P/L: N/A
Sold -100.00% shares
Q3 2022

Showing TOP 11 ARCH VENTURE MANAGEMENT's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of ARCH VENTURE MANAGEMENT, LLC?

The biggest position of the ARCH VENTURE MANAGEMENT, LLC is Karuna Therapeutics, Inc. (KRTX) with 38.28% portfolio share worth of 295.3M US dollars.

Top 5 ARCH VENTURE MANAGEMENT's holdings represent 96.32% of the portfolio:

  • Karuna Therapeutics, Inc. (KRTX) – 38.28%
  • EQRx, Inc. (EQRX) – 23.32%
  • Denali Therapeutics Inc. (DNLI) – 14.6%
  • Erasca, Inc. (ERAS) – 11.18%
  • Verve Therapeutics, Inc. (VERV) – 8.95%

Who is the portfolio manager of ARCH VENTURE MANAGEMENT, LLC?

The portfolio manager of the ARCH VENTURE MANAGEMENT, LLC is .

What is the total asset value of the ARCH VENTURE MANAGEMENT, LLC portfolio?

ARCH VENTURE MANAGEMENT, LLC total asset value (portfolio value) is 771.38M US dollars.

Who is ?

is the portfolio manager of the ARCH VENTURE MANAGEMENT, LLC.

What is (ARCH VENTURE MANAGEMENT, LLC) fund performance?

ARCH VENTURE MANAGEMENT's quarterly performance is +45.11%, annualy +714.36%.

What is the ARCH VENTURE MANAGEMENT, LLC CIK?

ARCH VENTURE MANAGEMENT's Central Index Key is 0001274403 .